Edition:
United Kingdom

Innate Pharma SA (IPH.PA)

IPH.PA on Paris Stock Exchange

5.88EUR
12:51pm BST
Change (% chg)

€0.09 (+1.55%)
Prev Close
€5.79
Open
€5.78
Day's High
€5.89
Day's Low
€5.74
Volume
77,854
Avg. Vol
196,683
52-wk High
€9.44
52-wk Low
€4.41

About

Innate Pharma SA is a France-based biopharmaceutical Company that develops drugs for treatment of cancer and inflammatory diseases. The Company identifies and characterizes drug candidates, selects indications and manages the pre-clinical and clinical development of products. Innate Pharma primarily focuses on the development of... (more)

Overall

Beta: 0.74
Market Cap(Mil.): €370.17
Shares Outstanding(Mil.): 63.93
Dividend: --
Yield (%): --

Financials

  IPH.PA Industry Sector
P/E (TTM): 145.40 109.48 62.40
EPS (TTM): 0.04 -- --
ROI: 1.40 7.96 11.78
ROE: 2.41 8.11 12.61

BRIEF-Innate Pharma Announces Updated Results On IPH4102

* ANNOUNCED ON MONDAY UPDATED RESULTS THAT SUPPORT ADVANCEMENT OF IPH4102 IN REFRACTORY SÉZARY SYNDROME

04 Dec 2018

Earnings vs. Estimates